Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.

Abstract

OBJECTIVES We aimed to identify molecular biomarkers for assessing the progression of intraductal papillary mucinous neoplasm of the pancreas (IPMN). METHODS We retrospectively investigated molecular aberrations and their associations with clinicopathological features in 172 IPMNs. RESULTS GNAS and KRAS mutations were detected in 48% and 56% of IPMNs… (More)
DOI: 10.1097/MPA.0000000000000253

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics